Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/checkpoint-inhibitors-applications-for-autoimmunity-frpoY8s24I
References (84)
-
J. Hughes, N. Vudattu, M. Sznol, S. Gettinger, H. Kluger, B. Lupsa, K. Herold (2015)
Precipitation of Autoimmune Diabetes With Anti-PD-1 ImmunotherapyDiabetes Care, 38
-
J. Zaretsky, A. García-Díaz, D. Shin, Helena Escuin-Ordinas, Willy Hugo, S. Hu-Lieskovan, D. Torrejon, Gabriel Abril-Rodriguez, Salemiz Sandoval, Lucas Barthly, Justin Saco, B. Moreno, R. Mezzadra, B. Chmielowski, K. Ruchalski, I. Shintaku, P. Sanchez, C. Puig-Saus, Grace Cherry, E. Seja, X. Kong, Jia Pang, B. Berent-Maoz, B. Comin-Anduix, T. Graeber, P. Tumeh, T. Schumacher, R. Lo, A. Ribas (2016)
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.The New England journal of medicine, 375 9
-
Yu‐Hwa Huang, Chen Zhu, Y. Kondo, A. Anderson, A. Gandhi, Andrew Russell, S. Dougan, B. Petersen, E. Melum, Thomas Pertel, K. Clayton, M. Raab, Qiang Chen, N. Beauchemin, P. Yazaki, M. Pyzik, M. Ostrowski, J. Glickman, C. Rudd, H. Ploegh, A. Franke, G. Petsko, V. Kuchroo, R. Blumberg (2014)
CEACAM1 regulates TIM-3-mediated tolerance and exhaustionNature, 517
-
Fang Wei, Shi Zhong, Z. Ma, H. Kong, Andrew Medvec, R. Ahmed, G. Freeman, M. Krogsgaard, J. Riley (2013)
Strength of PD-1 signaling differentially affects T-cell effector functionsProceedings of the National Academy of Sciences, 110
-
Li Wang, Rotem Rubinstein, J. Lines, A. Wasiuk, C. Ahonen, Yanxia Guo, Li-Fan Lu, David Gondek, Yan Wang, R. Fava, A. Fiser, S. Almo, R. Noelle (2011)
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responsesThe Journal of Experimental Medicine, 208
-
J. Miska, M. Abdulreda, P. Devarajan, J. Lui, J. Suzuki, A. Pileggi, P. Berggren, Zhibin Chen (2014)
Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft toleranceThe Journal of Experimental Medicine, 211
-
N. Patsoukis, Julia Brown, V. Petkova, Fang Liu, Lequn Li, V. Boussiotis (2012)
Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell ProliferationScience Signaling, 5
-
B. Kavanagh, S. O’Brien, David Lee, Yafei Hou, V. Weinberg, B. Rini, J. Allison, E. Small, L. Fong (2008)
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.Blood, 112 4
-
J. Sathish, K. Johnson, K. Fuller, F. Leroy, L. Meyaard, M. Sims, R. Matthews (2001)
Constitutive Association of SHP-1 with Leukocyte-Associated Ig-Like Receptor-1 in Human T Cells1The Journal of Immunology, 166
-
H. Läubli, C. Balmelli, M. Bossard, O. Pfister, K. Glatz, A. Zippelius (2015)
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanomaJournal for Immunotherapy of Cancer, 3
-
J. Schwartz, Xuewu Zhang, A. Fedorov, S. Nathenson, S. Almo (2001)
Structural basis for co-stimulation by the human CTLA-4/B7-2 complexNature, 410
-
P. Sharma, S. Hu-Lieskovan, J. Wargo, A. Ribas (2017)
Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 168
-
T. Asano, Yusuke Meguri, T. Yoshioka, Yuriko Kishi, M. Iwamoto, Makoto Nakamura, Y. Sando, H. Yagita, J. Koreth, Haesook Kim, E. Alyea, P. Armand, C. Cutler, V. Ho, J. Antin, R. Soiffer, Y. Maeda, M. Tanimoto, J. Ritz, K. Matsuoka (2017)
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.Blood, 129 15
-
M. Ruocco, K. Pilones, N. Kawashima, M. Cammer, Julie Huang, J. Babb, Mengling Liu, S. Formenti, Michael Dustin, S. Demaria (2012)
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.The Journal of clinical investigation, 122 10
-
Arlene Sharpe, E. Wherry, R. Ahmed, Gordon Freeman (2007)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infectionNature Immunology, 8
-
M. Baroja, L. Vijayakrishnan, E. Bettelli, P. Darlington, T. Chau, V. Ling, M. Collins, B. Carreno, J. Madrenas, V. Kuchroo (2002)
Inhibition of CTLA-4 Function by the Regulatory Subunit of Serine/Threonine Phosphatase 2A1The Journal of Immunology, 168
-
O. Qureshi, S. Kaur, T. Hou, L. Jeffery, Natalie Poulter, Zoe Briggs, R. Kenefeck, Anna Willox, S. Royle, J. Rappoport, D. Sansom (2012)
Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell ActivationThe Journal of Biological Chemistry, 287
-
A. Paterson, Scott Lovitch, P. Sage, Vikram Juneja, Youjin Lee, Justin Trombley, C. Arancibia-Cárcamo, R. Sobel, A. Rudensky, V. Kuchroo, G. Freeman, A. Sharpe (2015)
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunityThe Journal of Experimental Medicine, 212
-
Scott Mueller, T. Gebhardt, F. Carbone, W. Heath (2013)
Memory T cell subsets, migration patterns, and tissue residence.Annual review of immunology, 31
-
Carin Stamper, Yan Zhang, J. Tobin, D. Erbe, S. Ikemizu, S. Davis, M. Stahl, J. Seehra, W. Somers, L. Mosyak (2001)
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responsesNature, 410
-
Y. Maeda, H. Nishikawa, D. Sugiyama, D. Ha, M. Hamaguchi, Takuro Saito, M. Nishioka, J. Wing, D. Adeegbe, I. Katayama, S. Sakaguchi (2014)
Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individualsScience, 346
-
Taku Okazaki, S. Chikuma, Yoshiko Iwai, S. Fagarasan, T. Honjo (2013)
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical applicationNature Immunology, 14
-
Seng-Ryong Woo, Meghan Turnis, Monica Goldberg, Jaishree Bankoti, M. Selby, C. Nirschl, M. Bettini, D. Gravano, P. Vogel, C. Liu, Stephanie Tangsombatvisit, J. Grosso, G. Netto, M. Smeltzer, A. Chaux, P. Utz, C. Workman, D. Pardoll, A. Korman, C. Drake, D. Vignali
Microenvironment and Immunology Immune Inhibitory Molecules Lag-3 and Pd-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape -
W. Ouyang, J. Xue, Jing-mei Liu, W. Jia, Zhou Li, Xin Xie, Xue-song Liu, Jin-long Jian, Qi Li, Yong Zhu, A. Yang, Boquan Jin (2004)
Establishment of an ELISA system for determining soluble LAIR-1 levels in sera of patients with HFRS and kidney transplant.Journal of immunological methods, 292 1-2
-
C. Workman, K. Dugger, D. Vignali (2002)
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-31The Journal of Immunology, 169
-
W. Teft, T. Chau, J. Madrenas (2009)
Structure-Function analysis of the CTLA-4 interaction with PP2ABMC Immunology, 10
-
Bernice Lo, Jill Fritz, H. Su, G. Uzel, M. Jordan, M. Lenardo (2016)
CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency.Blood, 128 8
-
T. Shiratori, S. Miyatake, H. Ohno, C. Nakaseko, K. Isono, J. Bonifacino, T. Saito (1997)
Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2.Immunity, 6 5
-
A. Iwata, N. Watanabe, Yoshihiro Oya, T. Owada, K. Ikeda, A. Suto, S. Kagami, K. Hirose, Hiroko Kanari, Saki Kawashima, T. Nakayama, M. Taniguchi, I. Iwamoto, H. Nakajima (2009)
Protective Roles of B and T Lymphocyte Attenuator in NKT Cell-Mediated Experimental HepatitisThe Journal of Immunology, 184
-
Chen Zhu, A. Anderson, A. Schubart, H. Xiong, J. Imitola, S. Khoury, X. Zheng, T. Strom, V. Kuchroo (2005)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 6
-
N. Verma, S. Burns, Lucy Walker, D. Sansom (2017)
Immune deficiency and autoimmunity in patients with CTLA‐4 (CD152) mutationsClinical & Experimental Immunology, 190
-
Shengwu Liu, Honglian Zhang, Meng Li, Deqing Hu, C. Li, Baoxue Ge, B. Jin, Z. Fan (2012)
Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cellsCell Death and Differentiation, 20
-
Feng Xu, Jing Liu, Di Liu, Biao Liu, Min Wang, Zhiyuan Hu, Xuemei Du, Li Tang, F. He (2014)
LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses.Cancer research, 74 13
-
M. Munthe-Kaas, K. Carlsen, P. Helms, J. Gerritsen, M. Whyte, M. Feijen, Beate Skinningsrud, M. Main, G. Kwong, B. Lie, K. Carlsen, D. Undlien (2004)
CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigm.The Journal of allergy and clinical immunology, 114 2
-
10.1126/sciimmunol.aah4569
-
E. Tivol, F. Borriello, A. Schweitzer, William Lynch, J. Bluestone, Arlene Sharpe (1995)
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.Immunity, 3 5
-
Maya Gavrieli, N. Watanabe, S. Loftin, T. Murphy, K. Murphy (2003)
Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.Biochemical and biophysical research communications, 312 4
-
M. Nagasaka, Roba Alhasan, Marcus Crosby, Nithin Thummala, Seongho Kim, J. Abrams, A. Sukari (2017)
Toxicities associated with checkpoint inhibitor immunotherapy: The Karmanos Cancer Center experience.Journal of Clinical Oncology, 35
-
Silvia Marraco, N. Neubert, G. Verdeil, D. Speiser (2015)
Inhibitory Receptors Beyond T Cell ExhaustionFrontiers in Immunology, 6
-
S. Topalian, C. Drake, D. Pardoll (2015)
Immune checkpoint blockade: a common denominator approach to cancer therapy.Cancer cell, 27 4
-
Tony Jiang, T. Martinov, L. Xin, Jeremy Kinder, Justin Spanier, B. Fife, S. Way (2016)
Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity.Cell reports, 17 7
-
P. Waterhouse, J. Penninger, E. Timms, A. Wakeham, A. Shahinian, Kelvin Lee, C. Thompson, H. Griesser, T. Mak (1995)
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 270
-
T. Yokosuka, M. Takamatsu, Wakana Kobayashi-Imanishi, A. Hashimoto-Tane, M. Azuma, T. Saito (2012)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2The Journal of Experimental Medicine, 209
-
H. Läubli, C. Balmelli, Lukas Kaufmann, Michal Stanczak, Mohammedyaseen Syedbasha, Dominik Vogt, A. Hertig, B. Müller, O. Gautschi, F. Stenner, A. Zippelius, A. Egli, S. Rothschild (2018)
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse eventsJournal for Immunotherapy of Cancer, 6
-
M. Steinberg, O. Turovskaya, Raziya Shaikh, Gisen Kim, D. Mccole, K. Pfeffer, K. Murphy, C. Ware, M. Kronenberg (2008)
A crucial role for HVEM and BTLA in preventing intestinal inflammationThe Journal of Experimental Medicine, 205
-
A. Anderson, Nicole Joller, V. Kuchroo (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.Immunity, 44 5
-
Stuti Mehta, D. Cronkite, Megha Basavappa, Tahnee Saunders, Fatemeh Adiliaghdam, Hajera Amatullah, Sara Morrison, J. Pagan, Robert Anthony, P. Tonnerre, Georg Lauer, James Lee, Sreehaas Digumarthi, Lorena Pantano, Shannan Sui, Fei Ji, Ruslan Sadreyev, Chan Zhou, Alan Mullen, Vinod Kumar, Yang Li, C. Wijmenga, Ramnik Xavier, Terry Means, K. Jeffrey (2017)
Single-cell RNA-seq and computational analysis using temporal mixture modeling resolves TH1/TFH fate bifurcation in malariaScience Immunology, 2
-
Wong Yu, N. Jiang, Peter Ebert, B. Kidd, S. Müller, P. Lund, J. Juang, K. Adachi, Tiffany Tse, M. Birnbaum, E. Newell, Darrell Wilson, G. Grotenbreg, S. Valitutti, S. Quake, Mark Davis (2015)
Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.Immunity, 42 5
-
Michelle Hurchla, J. Šedý, Maya Gavrielli, C. Drake, T. Murphy, K. Murphy (2005)
B and T Lymphocyte Attenuator Exhibits Structural and Expression Polymorphisms and Is Highly Induced in Anergic CD4+ T Cells 1The Journal of Immunology, 174
-
Gabriel Abril-Rodriguez, A. Ribas (2017)
SnapShot: Immune Checkpoint Inhibitors.Cancer cell, 31 6
-
Elke Valk, Rufina Leung, H. Kang, K. Kaneko, C. Rudd, H. Schneider (2006)
T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor.Immunity, 25 5
-
Man Li, P. Xia, Ying Du, Shengwu Liu, Guanling Huang, Jun Chen, Honglian Zhang, N. Hou, Xuan Cheng, Luyu Zhou, Peifeng Li, Xiao Yang, Z. Fan (2014)
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling*The Journal of Biological Chemistry, 289
-
J. Fraser, M. Rincón, K. McCoy, G. Gros (1999)
CTLA4 ligation attenuates AP‐1, NFAT and NF‐κB activity in activated T cellsEuropean Journal of Immunology, 29
-
Wenchao Li, N. Blessin, R. Simon, M. Kluth, K. Fischer, C. Hube-Magg, Georgia Makrypidi-Fraune, B. Wellge, T. Mandelkow, N. Debatin, L. Pott, D. Höflmayer, M. Lennartz, G. Sauter, J. Izbicki, S. Minner, F. Büscheck, R. Uhlig, D. Dum, T. Krech, A. Luebke, C. Wittmer, F. Jacobsen, E. Burandt, S. Steurer, W. Wilczak, A. Hinsch (2018)
Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphomaBMC Cancer, 18
-
J. Lines, Eirini Pantazi, J. Mak, L. Sempere, Li Wang, S. O'Connell, S. Ceeraz, A. Suriawinata, Shaofeng Yan, M. Ernstoff, R. Noelle (2014)
VISTA is an immune checkpoint molecule for human T cells.Cancer research, 74 7
-
K. Wing, Yasush Onishi, P. Prieto-Martin, Tomoyuki Yamaguchi, M. Miyara, Z. Fehérvári, T. Nomura, S. Sakaguchi (2008)
CTLA-4 Control over Foxp3+ Regulatory T Cell FunctionScience, 322
-
SR Woo (2012)
10.1158/0008-5472.CAN-11-1620Cancer Res, 72
-
T. Gangadhar, R. Vonderheide (2014)
Mitigating the toxic effects of anticancer immunotherapyNature Reviews Clinical Oncology, 11
-
Yuwen Zhu, A. Paniccia, Alexander Schulick, Michelle Koenig, Joshua Byers, S. Bevers, B. Edil
Br Ief Definitive Repor T Identification of Cd112r as a Novel Checkpoint for Human T Cells -
Yuning Lu, H. Schneider, C. Rudd (2012)
Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.Blood, 120 23
-
Mahnaz Mellati, K. Eaton, B. Brooks-Worrell, W. Hagopian, R. Martins, J. Palmer, I. Hirsch (2015)
Anti–PD-1 and Anti–PDL-1 Monoclonal Antibodies Causing Type 1 DiabetesDiabetes Care, 38
-
C. Haymaker, Richard Wu, K. Ritthipichai, C. Bernatchez, M. Forget, J. Chen, Hiu-Lan Liu, E. Wang, F. Marincola, P. Hwu, L. Radvanyi (2013)
Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cellsJournal for Immunotherapy of Cancer, 1
-
K. Maasho, M. Masilamani, R. Valas, S. Basu, J. Coligan, F. Borrego (2005)
The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation.Molecular immunology, 42 12
-
N. Patsoukis, Kankana Bardhan, Pranam Chatterjee, Duygu Sari, Bianling Liu, L. Bell, Edward Karoly, G. Freeman, V. Petkova, P. Seth, Lequn Li, V. Boussiotis (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidationNature Communications, 6
-
Li Wang, I. Mercier, J. Putra, Wenna Chen, J. Liu, A. Schenk, E. Nowak, A. Suriawinata, Jiannan Li, R. Noelle (2014)
Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunityProceedings of the National Academy of Sciences, 111
-
L. Somer, S. Fevery, D. Bullens, O. Rutgeerts, C. Lenaerts, C. Mathieu, L. Boon, A. Kasran, M. Waer, A. Billiau (2010)
Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.Immunology letters, 133 1
-
Takeshi Takahashi, Tomoyuki Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T. Mak, S. Sakaguchi (2000)
Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4The Journal of Experimental Medicine, 192
-
Y Zhu (2016)
10.1084/jem.20150785J Exp Med, 213
-
Manu Rangachari, Chen Zhu, K. Sakuishi, S. Xiao, J. Karman, A. Chen, M. Angin, A. Wakeham, E. Greenfield, R. Sobel, H. Okada, P. Mckinnon, T. Mak, M. Addo, A. Anderson, V. Kuchroo (2012)
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustionNature Medicine, 18
-
O. Qureshi, Yong Zheng, Kyoko Nakamura, K. Attridge, Claire Manzotti, Emily Schmidt, Jennifer Baker, L. Jeffery, S. Kaur, Zoe Briggs, T. Hou, C. Futter, G. Anderson, L. Walker, D. Sansom (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4Science, 332
-
K. Kong, Guo Fu, Yaoyang Zhang, T. Yokosuka, J. Casas, Ann Canonigo-Balancio, S. Becart, Gisen Kim, J. Yates, M. Kronenberg, T. Saito, N. Gascoigne, A. Altman (2014)
Protein Kinase C-η Controls CTLA-4-Mediated Regulatory T Cell FunctionNature immunology, 15
-
Jianjun Gao, L. Shi, Hao Zhao, Jianfeng Chen, Liangwen Xiong, Qiu-ming He, Tenghui Chen, J. Roszik, C. Bernatchez, S. Woodman, Pei-Ling Chen, P. Hwu, J. Allison, A. Futreal, J. Wargo, P. Sharma (2016)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyCell, 167
-
M. Quigley, F. Pereyra, B. Nilsson, F. Porichis, Catia Fonseca, Q. Eichbaum, B. Julg, Jonathan Jesneck, Jonathan Jesneck, Kathleen Brosnahan, S. Imam, Kate Russell, I. Toth, A. Piechocka-Trocha, D. Dolfi, Jill Angelosanto, Alison Crawford, Haina Shin, D. Kwon, J. Zupkosky, Loise Francisco, G. Freeman, E. Wherry, Daniel Kaufmann, Daniel Kaufmann, B. Walker, Benjamin Ebert, Benjamin Ebert, Benjamin Ebert, W. Haining (2010)
Integrative genomic analysis of HIV-specific CD8+ T cells reveals that PD-1 inhibits T cell function by upregulating BATFNature medicine, 16
-
Judong Lee, Binh Phong, A. Egloff, L. Kane (2011)
TIM polymorphisms—genetics and functionGenes and Immunity, 12
-
T. Yokosuka, Wakana Kobayashi, M. Takamatsu, K. Sakata-Sogawa, H. Zeng, A. Hashimoto-Tane, H. Yagita, M. Tokunaga, T. Saito (2010)
Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation.Immunity, 33 3
-
N. Verma, S. Burns, L. Walker, D. Sansom (2017)
Immune deficiency and autoimmunity in patients with CTLA-4 mutations -
S. Gough, L. Walker, D. Sansom (2005)
CTLA4 gene polymorphism and autoimmunityImmunological Reviews, 204
-
F. Legoux, Jong-Baeck Lim, Andrew Cauley, Stanislav Dikiy, James Ertelt, T. Mariani, T. Sparwasser, S. Way, J. Moon (2015)
CD4+ T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion.Immunity, 43 5
-
E. Nowak, J. Lines, F. Varn, Jie Deng, Aurelien Sarde, R. Mabaera, A. Kuta, I. Mercier, Chao Cheng, R. Noelle (2017)
Immunoregulatory functions of VISTAImmunological Reviews, 276
-
K. Yasuda, M. Nagafuku, T. Shima, M. Okada, T. Yagi, T. Yamada, Yasuko Minaki, Akiko Kato, S. Tani-ichi, T. Hamaoka, A. Kosugi (2002)
Cutting Edge: Fyn Is Essential for Tyrosine Phosphorylation of Csk-Binding Protein/Phosphoprotein Associated with Glycolipid-Enriched Microdomains in Lipid Rafts in Resting T Cells1The Journal of Immunology, 169
-
L. Marengère, P. Waterhouse, G. Duncan, H. Mittrücker, G. Feng, T. Mak (1996)
Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4Science, 272
-
Baihao Zhang, S. Chikuma, S. Hori, S. Fagarasan, T. Honjo (2016)
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse modelProceedings of the National Academy of Sciences, 113
-
Nicole Joller, J. Hafler, B. Brynedal, N. Kassam, S. Spoerl, S. Levin, A. Sharpe, V. Kuchroo (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory FunctionsThe Journal of Immunology, 186
-
H. Schneider, Jos Downey, Andrew Smith, B. Zinselmeyer, C. Rush, J. Brewer, B. Wei, N. Hogg, P. Garside, C. Rudd (2006)
Reversal of the TCR Stop Signal by CTLA-4Science, 313
- Publisher
- Springer Journals
- Copyright
- Copyright © 2017 by Springer Science+Business Media, LLC
- Subject
- Medicine & Public Health; Allergology
- ISSN
- 1529-7322
- eISSN
- 1534-6315
- DOI
- 10.1007/s11882-017-0740-z
- pmid
- 28956259
- Publisher site
- See Article on Publisher Site
Abstract
To limit excessive T cell-mediated inflammatory responses, the immune system has a milieu of inhibitory receptors, called immune checkpoints. Cancer cells have evolved to seize those inhibitory pathways and to prevent T cell-mediated killing of tumor cells. Therefore, immune checkpoint inhibitors (ICI) consisting of blocking antibodies against these receptors present an exciting avenue in the fight against cancer. The last decade has seen the implementation of ICI against a variety of cancer indications that have improved the overall anti-tumor responses and patient survival. However, inflammatory toxicities and autoimmunity are a significant adverse event of ICI therapies. In this review, we will discuss the biology of immune checkpoints, highlight research strategies that may help reduce the incidence of immune-related adverse events associated with ICI therapies, and also suggest investigational approaches to manipulate immune checkpoints to treat primary autoimmune disorders.
Journal
Current Allergy and Asthma Reports – Springer Journals
Published: Sep 27, 2017